Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Accumulated Expenses (2016 - 2025)

InspireMD filings provide 14 years of Accumulated Expenses readings, the most recent being $1.5 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 16.6% to $1.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.5 million, a 16.6% increase, with the full-year FY2025 number at $1.5 million, up 16.6% from a year prior.
  • Accumulated Expenses hit $1.5 million in Q4 2025 for InspireMD, up from $735000.0 in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $2.2 million in Q4 2023 to a low of $233000.0 in Q4 2021.
  • Median Accumulated Expenses over the past 5 years was $918500.0 (2025), compared with a mean of $891200.0.
  • Biggest five-year swings in Accumulated Expenses: skyrocketed 2046.67% in 2021 and later plummeted 77.42% in 2023.
  • InspireMD's Accumulated Expenses stood at $233000.0 in 2021, then soared by 137.77% to $554000.0 in 2022, then skyrocketed by 294.95% to $2.2 million in 2023, then crashed by 39.44% to $1.3 million in 2024, then grew by 16.6% to $1.5 million in 2025.
  • The last three reported values for Accumulated Expenses were $1.5 million (Q4 2025), $735000.0 (Q3 2025), and $1.0 million (Q2 2025) per Business Quant data.